ArticleFrontiers in nutrition2025
BRI shows stronger association than BMI for MACE in patients with T2DM: insights from the ACCORD study.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT00000620. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study investigated the associations of the body roundness index (BRI) with major adverse cardiovascular events (MACEs, including non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death) and total mortality (TM) in patients with type 2 diabetes mellitus (T2DM) from the ACCORD/ACCORDION cohort. Methods: During a median follow-up of 8.82 years, a total of 1,802 participants (17.76%) experienced MACEs, and 1,926 participants (18.98%) died from all causes. We used Cox proportional hazards regression models to evaluate the association of BRI and body mass index (BMI) with MACEs and TM. Non-linear dynamics between BRI and these outcomes were probed via restricted cubic spline and smooth curve-fitting, identifying pivotal risk thresholds. Comprehensive subgroup and sensitivity analyses were implemented to validate the consistency of the results. Results: The findings from multivariate Cox regression models, after adjusting for potential confounders, indicated that elevated BRI levels were a significant risk factor for MACEs and TM. A unit rise in BRI was associated with a 3% heightened risk of MACEs and a 6% increase in TM. Patients in the highest tertile of baseline BRI faced a 1.14 fold and a 1.27 fold elevated risk of MACEs and TM, respectively, relative to those in the lowest tertile. In contrast, the same multivariate regression analysis showed no significant association between baseline BMI quartiles and MACEs. Notably, the associations of BRI with MACEs and TM were comparable to those observed for the waist-to-height ratio (WHtR) and the conicity index. Additionally, our analysis delineated a nonlinear correlation between BRI and both types of mortality, pinpointing inflection points at 4.39 for cardiovascular mortality and 4.24 for TM via a recursive methodology. Conclusion: An elevated BRI was significantly associated with a higher risk of MACEs and TM in our cohort of patients with T2DM. BRI may serve as a useful indicator for assessing cardiovascular risk in patients with T2DM. Clinical trial registration: https://clinicaltrials.gov/ct2/show/NCT00000620, NCT00000620.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.